Where do we stand in developing radionuclides against molecular markers overexpressed on breast cancer (BC) cells such as EGFR-family members?
Willy Vangu
nuclear medicine, Johannesburg, South Africa
nuclear medicine, Johannesburg, South Africa
New User? Click here to register
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Text generated by AI based on an exclusive interview, revised and reviewed by
Copyright © 2025 - BCU
Hi, this is a comment.
To get started with moderating, editing, and deleting comments, please visit the Comments screen in the dashboard.
Commenter avatars come from Gravatar.